151.00
+7.00
+(4.86%)
At close: January 31 at 8:20:01 AM GMT+1
Research analysis
Earnings estimate
Currency in USD | Current qtr. (Mar 2025) | Next qtr. (Jun 2025) | Current year (2025) | Next year (2026) |
---|---|---|---|---|
No. of analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low estimate | 0 | 0 | 0 | 0 |
High estimate | 0 | 0 | 0 | 0 |
Year ago EPS | -- | -- | -- | -- |
Revenue estimate
Currency in USD | Current qtr. (Mar 2025) | Next qtr. (Jun 2025) | Current year (2025) | Next year (2026) |
---|---|---|---|---|
No. of analysts | 9 | 9 | 10 | 10 |
Avg. Estimate | 262.52M | 263.78M | 980.42M | 1.1B |
Low estimate | 261.1M | 252.3M | 956.57M | 1.06B |
High estimate | 263.7M | 273.4M | 984.3M | 1.14B |
Year ago sales | 223.29M | 224.67M | 839.25M | 980.42M |
Sales growth (year/est) | 17.57% | 17.41% | 16.82% | 12.64% |
EPS trend
Currency in USD | Current qtr. (Mar 2025) | Next qtr. (Jun 2025) | Current year (2025) | Next year (2026) |
---|---|---|---|---|
Current estimate | 0 | 0 | 0 | 0 |
7 days ago | 0 | 0 | 0 | 0 |
30 days ago | 0 | 0 | 0 | 0 |
60 days ago | 0 | 0 | 0 | 0 |
90 days ago | 0 | 0 | 0 | 0 |
EPS revisions
Currency in USD | Current qtr. (Mar 2025) | Next qtr. (Jun 2025) | Current year (2025) | Next year (2026) |
---|---|---|---|---|
Up last 7 days | -- | -- | -- | -- |
Up last 30 days | -- | -- | -- | -- |
Down last 7 days | -- | -- | -- | -- |
Down last 30 days | -- | -- | -- | -- |
Growth estimates
Current qtr. | Next qtr. | Current year | Next year | |
---|---|---|---|---|
D6I.F | -- | -- | -- | -- |
S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & downgrades
Upgrade | William Blair: Market Perform to Outperform | 1/30/2025 |
Reiterates | Guggenheim: Neutral to Neutral | 1/29/2025 |
Maintains | Keybanc: Overweight to Overweight | 1/29/2025 |
Maintains | Cantor Fitzgerald: Neutral to Neutral | 1/29/2025 |
Initiated | Keybanc: Overweight | 1/16/2025 |
Initiated | Cantor Fitzgerald: Neutral | 1/16/2025 |